Skip to main content

ORGANOIDES HUMANOS COMO MODELOS DEL TRACTO REPRODUCTIVO FEMENINO SANO UTILIZANDO SOPORTES NATIVOS DE BIOINGENIERIA Y SUS APLICACIONES PRECLINICAS EN EL CAMPO DE LA MEDICINA GINECOLOGICA.

PI21/00305

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2021
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARA LA INVESTIGACION DEL HOSPITAL LA FE
Execution centre INSTITUTO DE INVESTIGACION SANITARIA HOSPITAL LA FE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

N-acetylcysteine and raloxifene boost photodynamic therapy against cutaneous squamous cell carcinoma by decreasing TGF β1 secreted by cancer-associated fibroblasts

  • Gallego-Rentero, María
  • Botella, Luisa María
  • Mascaraque, Marta
  • Nicolás-Morala, Jimena
  • Albiñana, Virginia
  • Abarca-Lachen, Edgar
  • Gilaberte, Yolanda
  • González, Salvador
  • Juarranz, Ángeles
  • Carrasco, Elisa
Cutaneous squamous cell carcinoma (cSCC) is a highly prevalent skin cancer. While surgery remains the gold standard treatment, non-invasive methods like photodynamic therapy (PDT) stand out for their high efficacy and minimal cosmetic impact. However, resistance to PDT is still a challenge. Numerous cellular processes involved in cancer biology and therapy resistance are regulated by the TGFβ1/SMAD pathway. Using in vitro bidimensional and tridimensional cultures of cSCC cell lines, we studied the development of resistance to PDT in response to TGFβ1 secreted by cancer associated fibroblasts. Our results highlight the TGFβ1 co-receptor endoglin as a key molecular player in the process. Importantly, targeting endoglin expression with N-acetylcysteine (NAC) or raloxifene significantly reduced TGFβ1 levels and effectively prevented resistance. In addition, the combination of PDT with NAC resulted in an improved therapeutic outcome in vivo in SKH-1 mice with cSCC photogenerated by chronic exposition to ultraviolet light. In conclusion, the combination of PDT with NAC or raloxifene enhances PDT efficacy by mitigating resistance mechanisms, which can open new avenues for the treatment of cSCC, This research was funded by Instituto de Salud Carlos III (ISCIII) through the Projects PI21/00305, PI21/00953, PI24/00687, PI24/01091 and co-funded by the European Union, and by funding from the B59-23D research group, Gobierno de Aragón (Spain)., Peer reviewed